Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulin-like growth factor binding protein proteolysis.

R Clay Bunn1, John L Fowlkes

  • 1Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock, AR 72202, USA. bunnrobertc@uams.edu

Trends in Endocrinology and Metabolism: TEM
|April 26, 2003
PubMed
Summary

Proteases degrade insulin-like growth factor-binding proteins (IGFBPs), increasing free insulin-like growth factors (IGFs) available to activate cell receptors. This IGFBP proteolysis impacts cell survival and differentiation, with implications for various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes.

Journal of cellular and molecular medicine·2026
Same author

Effect of Canagliflozin Pretreatment on the Efficacy of Insulin Therapy to Rescue Type 1 Diabetes-Related Bone Fragility in Male Mice.

Calcified tissue international·2026
Same author

A myostatin inhibitory antibody combined with insulin, partially rescues the musculoskeletal phenotype of female insulin-deficient diabetic mice.

Frontiers in endocrinology·2025
Same author

Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset.

Diabetes research and clinical practice·2025
Same author

LCoRL Regulates Growth and Metabolism.

Endocrinology·2024
Same author

Biomechanical Stimulation of Muscle Constructs Influences Phenotype of Bone Constructs by Modulating Myokine Secretion.

JBMR plus·2023

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Insulin-like growth factors (IGFs) bind to insulin-like growth factor-binding proteins (IGFBPs) with high affinity, inhibiting IGFs from activating the type 1 IGF receptor.
  • IGFBP proteolysis releases IGFs, enhancing their availability to bind and activate IGF receptors.
  • This process is crucial for regulating IGF receptor signaling, which influences cell survival, proliferation, and differentiation.

Purpose of the Study:

  • To review the recent advancements in understanding IGFBP proteolysis.
  • To highlight the role of IGFBP proteolysis in modulating IGF receptor signaling.
  • To discuss the pathological relevance of altered IGFBP proteolysis.

Main Methods:

  • Literature review focusing on recent studies in IGFBP proteolysis.

Related Experiment Videos

  • Analysis of the biochemical mechanisms of IGFBP degradation by proteases.
  • Synthesis of findings regarding the functional consequences of IGFBP fragments.

    • Main Results:

    • Several novel IGFBP proteases have been identified.
    • IGFBP fragments can exert IGF-independent biological actions.
    • Dysregulation of IGFBP proteolysis is associated with several pathological conditions.

    Conclusions:

    • IGFBP proteolysis is a key regulatory mechanism controlling IGF receptor signaling.
    • Understanding IGFBP proteolysis offers insights into disease pathogenesis.
    • Further research into IGFBP proteolysis may reveal new therapeutic targets.